| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 44.711 | 47.895 | 62.589 | 62.667 | 12.393 | 26.880 | 47.279 | 75.543 | 69.430 |
| Total Income - EUR | - | 44.711 | 47.895 | 62.589 | 62.667 | 12.393 | 26.880 | 47.279 | 75.543 | 70.803 |
| Total Expenses - EUR | - | 4.892 | 6.868 | 4.498 | 4.090 | 4.652 | 5.148 | 7.835 | 10.936 | 15.566 |
| Gross Profit/Loss - EUR | - | 39.819 | 41.027 | 58.092 | 58.577 | 7.741 | 21.732 | 39.444 | 64.606 | 55.237 |
| Net Profit/Loss - EUR | - | 38.924 | 39.781 | 56.214 | 56.697 | 7.369 | 20.926 | 38.026 | 63.851 | 53.113 |
| Employees | - | 2 | 4 | 3 | 0 | 0 | 3 | 3 | 3 | 2 |
Check the financial reports for the company - Alfa Med Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 44.803 | 48.708 | 67.833 | 61.468 | 10.444 | 27.730 | 48.545 | 74.079 | 66.375 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 30.897 | 17.608 | 17.113 | 1.567 | 1.482 | 0 | 5.037 | 5.921 | 53.538 |
| Cash | - | 13.906 | 31.100 | 50.720 | 59.901 | 8.963 | 27.730 | 43.507 | 68.159 | 12.837 |
| Shareholders Funds | - | 38.991 | 39.860 | 56.291 | 56.773 | 7.444 | 20.999 | 38.099 | 63.924 | 53.185 |
| Social Capital | - | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | - | 5.812 | 8.848 | 11.541 | 4.695 | 3.170 | 6.731 | 10.446 | 10.156 | 13.190 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alfa Med Plus Srl